The Hematology and Oncology Clinics of three US medical centres - Dartmouth-Hitchcock Medical Center (Lebanon, NH), Pacific Shores Medical Group (Long Beach, CA) and South Carolina Oncology Associates ...
Value of caregiver ratings in evaluating the quality of life of patients with cancer. More than 500 community-based oncologists enrolled 2,342 patients with malignancies undergoing cytotoxic ...
Please provide your email address to receive an email when new articles are posted on . Hospira Inc. presented two studies that demonstrate the pharmacokinetic and pharmacodynamic equivalence of its ...
Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. Two thousand three hundred seventy patients with nonmyeloid malignancies who ...
Please provide your email address to receive an email when new articles are posted on . The FDA today approved epoetin alfa-epbx, the first epoetin alfa biosimilar, for the treatment of anemia caused ...
The FDA has approved Pfizer’s epoetin alfa-epbx (Retacrit), a biosimilar to epoetin alfa (Epogen), marking the first biosimilar approval of 2018 and the first biosimilar erythropoiesis-stimulating ...
CHICAGO -- Patients with transfusion-dependent, low-risk myelodysplastic syndromes (MDS) needed significantly fewer transfusions when treated with luspatercept (Reblozyl) for anemia compared with the ...
BRIDGEWATER, N.J., March 7 /PRNewswire/ -- Ortho Biotech Products, L.P. today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the U.S. Food and Drug ...
In a phase 3 study, the mean hemoglobin change from baseline to average was significantly higher among roxadustat-treated patients compared with epoetin alfa recipients, according to investigators.
Credit: Shutterstock Newly released safety data also show that roxadustat is associated with reduced cardiovascular risks compared with epoetin alfa. WASHINGTON—Roxadustat is superior to epoetin alfa ...
A total of 124 patients participated in the study at three sites: Dartmouth (n = 43 patients), Pacific Shores (n = 68) and South Carolina (n = 13). Time and resource data were collected for 177 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results